Tomer Gold
Technik-/Wissenschafts-/F&E-Leiter bei Dexcel Pharma Technologies Ltd.
Profil
Tomer Gold is currently the Vice President-Research & Development at Dexcel Pharma Technologies Ltd.
He previously worked as an Independent Director at Cynapsus Therapeutics, Inc. from 2014 to 2016.
Mr. Gold received his undergraduate and graduate degrees from Technion-Israel Institute of Technology.
Aktive Positionen von Tomer Gold
| Unternehmen | Position | Beginn |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Ehemalige bekannte Positionen von Tomer Gold
| Unternehmen | Position | Ende |
|---|---|---|
| CYNAPSUS THERAPEUTICS INC | Direktor/Vorstandsmitglied | 21.10.2016 |
Ausbildung von Tomer Gold
| Technion-Israel Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
